TTRX
Turn Therapeutics Inc.
12.40$
-7.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 24 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | – | +9.5% | +3.5% | +2.1% | +0.6% | – | |
| – | – | -17.2% | +556.0% | +9.5% | +49.3% | – | |
| – | – | +85.9% | -42.0% | -200.6% | – | – | |
| – | – | +2,244,750.0% | -100.0% | +0.0% | +33.3% | – | |
| – | – | +182.8% | -65.0% | -61.1% | -52.6% | – | |
| – | – | – | – | – | -100.0% | – | |
| – | – | -72.3% | +434.4% | +145.0% | -100.0% | – | |
| – | – | -102.6% | – | +211.8% | -115.1% | – | |
| – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.